Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's record demand for Dupixent, state of drug innovation in Europe, company outlook, and more. More for You.

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, 2025 outlook, drug pipeline, the company's dividend and buyback decision, his thoughts on the ...

Sanofi CEO Paul Hudson speaks during the Competing In The Global Marketplace: Strategies for Growth panel, at the Fortune Global Forum on Nov. 11, 2024 in New York City.

Sanofi Chief Executive Paul Hudson said the Blueprint acquisition had been in the making for a long time and that work started long before last week’s update. “We’ve had a bit of a bumpy ...

Sanofi (NASDAQ:SNY) 43rd Annual J.P. Morgan Healthcare January 14, 2025 12:45 PM ETCompany Participants. Paul Hudson - Chief Executive Officer Francois-Xavier Roger - Chief Financial Officer ...

The revamp of French drugmaker Sanofi under new chief executive Paul Hudson has filtered up to top management, with four senior figures leaving the company. The move comes shortly after Hudson ...

France's Sanofi has agreed to buy US-based Blueprint Medicines Corp. for over $9 billion to boost its position in rare immunology diseases, in what would be the biggest health care deal in Europe this ...

MORRISTOWN − Gov. Phil Murphy joined Sanofi CEO Paul Hudson on May 22 for the formal grand-opening of French pharmaceutical giant Sanofi's new U.S. flagship office , the home for about 2,000 ...

Hudson says many CEOs are scared of AI, comparing it to The Terminator’s John Connor traveling back in time to stop the rise of the machines. Sanofi CEO Paul Hudson takes inspiration from ...